November 21, 2011
Takeda Pharmaceutical Co. Ltd. launched its latest attack Wednesday in New York federal court seeking to prevent generic-drug maker Hetero Drugs Ltd. and several subsidiaries from producing their own version of the blockbuster diabetes drug Actos.